FDA Inspection 662789 — LPNA Group Inc.

LPNA Group Inc. — FEI 1000120219

The FDA completed an inspection of LPNA Group Inc. on May 7, 2010 in Tonawanda, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 7, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tonawanda, NY (United States)

Citations

IDCFRDescription
191221 CFR 211.166(a)Written program not followed
203121 CFR 211.194(a)Complete test data included in records
440221 CFR 211.192Written record of investigation incomplete